Table 2 Association of clinicopathological parameters and PODXL expression by polyclonal and monoclonal antibodies combined
From: A comparative study of two PODXL antibodies in 840 colorectal cancer patients
PODXL expression | ||||
|---|---|---|---|---|
Low | Moderate | High | ||
n (%) | 714 (88.4) | 79 (9.8) | 14 (1.7) | p-value |
Age, years | ||||
<65 | 300 (42.0) | 38 (48.1) | 5 (35.7) | 0.643 |
≥ 65 | 414 (58.0) | 41 (51.9) | 9 (64.3) | |
Gender | ||||
Male | 398 (55.7) | 41 (51.9) | 7 (50.0) | 0.450 |
Female | 316 (44.3) | 38 (48.1) | 7 (50.0) | |
Dukes | ||||
A | 113 (15.8) | 4 (5.1) | 0 (0.0) | < 0.0001 |
B | 257 (36.0) | 26 (32.9) | 2 (14.3) | |
C | 187 (26.2) | 32 (40.5) | 2 (14.3) | |
D | 157 (22.0) | 17 (21.5) | 10 (71.4) | |
Grade (WHO) | ||||
1 | 28 (3.9) | 0 (0.0) | 0 | < 0.0001 |
2 | 513 (72.4) | 32 (40.5) | 3 (21.4) | |
3 | 149 (21.0) | 37 (46.8) | 9 (64.3) | |
4 | 19 (2.7) | 10 (12.7) | 2 (14.3) | |
Missing | 5 | |||
Location | ||||
Colon | 362 (50.7) | 49 (62.0) | 7 (50.0) | 0.168 |
Rectum | 352 (49.3) | 30 (38.0) | 7 (50.0) | |
Side | ||||
Right | 185 (25.9) | 32 (40.5) | 6 (42.9) | 0.003 |
Left | 529 (74.1) | 47 (59.5) | 8 (57.1) | |
Histology | ||||
Adenomatous | 639 (89.6) | 70 (88.6) | 13 (92.9) | 0.879 |
Mucinous | 74 (10.4) | 9 (11.4) | 1 (7.1) | |
Missing | 1 | |||